A to X: The problem of categorisation of drugs in pregnancy? An Australian perspective

Medical Journal of Australia

Volumn 195, Issue 10, 2011, Pages 572-574

  Kennedy, Debra S ^a,b  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; MINERAL; MIRTAZAPINE; PAROXETINE; TETRACYCLINE; THALIDOMIDE; VALPROIC ACID; VITAMIN; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ALTERNATIVE MEDICINE; ANEMIA; ARTICLE; ASTHMA; AUSTRALIA; BIRTH DEFECT; BLEEDING; BREAST FEEDING; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG LABELING; DRUG SAFETY; DRUG USE; HUMAN; PREGNANCY; PRENATAL DRUG EXPOSURE; RISK FACTOR; THROMBOSIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG TOXICITY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; METHODOLOGY; NEWBORN; PATIENT EDUCATION; PREGNANCY COMPLICATION; RISK ASSESSMENT;

AUSTRALIA; DRUG TOXICITY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; NONPRESCRIPTION DRUGS; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; PRESCRIPTION DRUGS; RISK ASSESSMENT;

EID: 84856069771     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.11119     Document Type: Article

References (12)

1. Henry A, Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study. Aust N Z J Obstet Gynaecol 2000; 40: 165-172.
2. Sawicki E, Stewart K, Wong S, et al. Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol 2011; 51: 333-338.
3. MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust 2006; 184: 27-31.
4. Skouteris H, Wertheim EH, Rallis S, et al. Use of complementary and alternative medicines by a sample of Australian women during pregnancy. Aust N Z J Obstet Gynaecol 2008; 48: 384-390.
5. Medicines in Pregnancy Working Party, Australian Drug Evaluation Committee. Prescribing medicines in pregnancy: an Australian categorisation of risk of drug use in pregnancy. 4th ed. Canberra: Therapeutics Goods Administration, 1999.
6. Therapeutics Goods Administration. Prescribing medicines in pregnancy database. http://www.tga.gov.au/hp/medicines-pregnancy.htm (accessed Oct 2011).
7. Kennedy D, Taylor T, Cupitt D, et al. Practical knowledge about drugs in pregnancy and breastfeeding: a survey of pharmacists and general practitioners in NSW [abstract]. Birth Defects Res A Clin Mol Teratol 2011; 91: 410-412.
8. Jones KL, Johnson DL, Van Maarseveen ND, et al. Salmeterol use and pregnancy outcome: a prospective multi-center study [abstract]. J Allergy Clin Immunol 2002; 109: S156.
9. Rey E, Boulet LP. Asthma in pregnancy. BMJ 2007; 334: 582-585.
10. Lim J, Sullivan E, Kennedy D. MotherSafe: review of three years of counseling by an Australian teratology information service. Aust N Z J Obstet Gynaecol 2009; 49: 168-172.
11. Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol 2002; 187: 333-339.
12. Kweder SL. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Birth Defects Res A Clin Mol Teratol 2008; 82: 605-609.